Novavax Inc (NVV1.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 09:01AM CEST. Market open.
| Previous close | 14.57 |
| Open | 14.56 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 14.56 - 14.56 |
| 52-week range | 3.41 - 23.80 |
| Volume | |
| Avg. volume | 3,864 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
- Zacks
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- Simply Wall St.
Novavax, Inc. (NASDAQ:NVAX) has caught the attention of institutional investors who hold a sizeable 49% stake
Key Insights Institutions' substantial holdings in Novavax implies that they have significant influence over the...
© 2024 Yahoo. All rights reserved.